<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>diabetes in colombia &#8211; Global Health Intelligence – Healthcare Market Insights for Emerging Markets</title>
	<atom:link href="https://globalhealthintelligence.com/tag/diabetes-in-colombia/feed/" rel="self" type="application/rss+xml" />
	<link>https://globalhealthintelligence.com</link>
	<description>The leading source for hospital data and market intelligence across Latin America and Asia.</description>
	<lastBuildDate>Mon, 01 Dec 2025 19:25:24 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://globalhealthintelligence.com/wp-content/uploads/2025/11/cropped-Profile-32x32.png</url>
	<title>diabetes in colombia &#8211; Global Health Intelligence – Healthcare Market Insights for Emerging Markets</title>
	<link>https://globalhealthintelligence.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Prevalence of diabetes in Mexico higher than US, Argentina, Brazil, Chile and Colombia</title>
		<link>https://globalhealthintelligence.com/news/prevalence-diabetes-mexico-higher-us-argentina-brazil-chile-colombia/</link>
		
		<dc:creator><![CDATA[GHI Analysis]]></dc:creator>
		<pubDate>Wed, 09 Nov 2016 00:34:35 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[diabetes in argentina]]></category>
		<category><![CDATA[diabetes in brazil]]></category>
		<category><![CDATA[diabetes in Chile]]></category>
		<category><![CDATA[diabetes in colombia]]></category>
		<category><![CDATA[diabetes in mexico]]></category>
		<category><![CDATA[diabetes prevalance brazil]]></category>
		<category><![CDATA[diabetes prevalence mexico]]></category>
		<category><![CDATA[hospital database mexico]]></category>
		<category><![CDATA[hospital equipment mexico]]></category>
		<category><![CDATA[market research mexico healthcare]]></category>
		<category><![CDATA[mexican hospital database]]></category>
		<category><![CDATA[mexican hospitals data]]></category>
		<category><![CDATA[mexican hospitals market research]]></category>
		<category><![CDATA[mexico hospital data]]></category>
		<category><![CDATA[mexico market intelligence healthcare]]></category>
		<category><![CDATA[number of hospitals in mexico]]></category>
		<category><![CDATA[number of private hospitals in mexico]]></category>
		<category><![CDATA[number of public hospitals in mexico]]></category>
		<guid isPermaLink="false">https://globalhealthintelligence.com/?p=3131</guid>

					<description><![CDATA[According to the International Diabetes Federation, in 2015, the prevalence of diabetes in Mexico was estimated to be 14.7%, which translated to 17.6 million people affected by the condition. This indicator put Mexico above countries such as the United States (12.8%), Argentina (6.2%), Brazil (10.2%), Chile (11%) and Colombia (9.6%).]]></description>
										<content:encoded><![CDATA[<p>&nbsp;</p>
<p>According to the International Diabetes Federation, in 2015, the prevalence of diabetes in <a href="https://globalhealthintelligence.com/ghi-analysis/mexico-hospital-demographics-2016-latin-americas-second-largest-hospital-market-road-gain-efficiencies/" target="_blank" rel="noopener">Mexico</a> was estimated to be 14.7%, which translated to 17.6 million people affected by the condition. This indicator put Mexico above countries such as the United States (12.8%), <a href="https://globalhealthintelligence.com/ghi-analysis/top-hospitals-argentina/" target="_blank" rel="noopener">Argentina</a> (6.2%), <a href="https://globalhealthintelligence.com/news/brazilian-health-industry-invests-innovation-quality-owing-increased-domestic-demand-medical-devices/" target="_blank" rel="noopener">Brazil</a> (10.2%), <a href="https://globalhealthintelligence.com/ghi-analysis/top-hospitals-chile/" target="_blank" rel="noopener">Chile</a> (11%) and <a href="https://globalhealthintelligence.com/ghi-analysis/top-hospitals-colombia/" target="_blank" rel="noopener">Colombia</a> (9.6%). The Mexican Institute of Social Security (IMSS) disbursed USD 44 billion to treat the condition in 2015. The average cost of treatment per patient amounted to over USD 16,000 annually. Dulce Wireless Tijuana project, which began to take shape in 2011, is a multisectoral, binational effort carried out in the border areas of <a href="https://globalhealthintelligence.com/ghi-analysis/mexico-hospital-demographics-2016-latin-americas-second-largest-hospital-market-road-gain-efficiencies/" target="_blank" rel="noopener">Mexico</a> with the aim to improve monitoring and care provided to patients with diabetes, through the use of 3G wireless technology and the use of mobile devices feature phones in a first stage, later, smart phones or smartphones are implemented. The project demonstrated the positive impact of mobile technology in the treatment of <a href="https://globalhealthintelligence.com/news/mexican-healthcare-system-witnesses-great-progress-over-last-decade-but-needs-to-focus-more-on-serious-challenges-oecd/" target="_blank" rel="noopener">type 2 diabetes</a>. Monitoring and control based on mobile technologies contribute to reducing some costs associated with standard treatment. Finally, the project not only generated positive impacts on the health of people, but also in digital literacy.</p>
<p>&nbsp;</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
